Cost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare

Comorbidity is more common in older patients and can increase the cost of care by increasing toxicity. Using the SEER-Medicare database from 2000 to 2007, we examined the costs and life-year benefit of Auto-HSCT for MM patients over the age of 65 by evaluating the difference over time relative to co...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Gunjan L., Winn, Aaron, Lin, Pei-Jung, Klein, Andreas, Sprague, Kellie A., Smith, Hedy P., Buchsbaum, Rachel, Cohen, Joshua T., Miller, Kenneth B., Comenzo, Raymond, Parsons, Susan K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088316/
https://www.ncbi.nlm.nih.gov/pubmed/27830092
http://dx.doi.org/10.1155/2016/3645623

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088316/
https://www.ncbi.nlm.nih.gov/pubmed/27830092
http://dx.doi.org/10.1155/2016/3645623

Ejemplares similares